(TAP) Molson Coors Brewing - Overview
Stock: Beer, Cider, Seltzer, Spirits
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.63% |
| Yield on Cost 5y | 4.36% |
| Yield CAGR 5y | 28.95% |
| Payout Consistency | 94.7% |
| Payout Ratio | 34.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.0% |
| Relative Tail Risk | -2.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -17.31 |
| Character TTM | |
|---|---|
| Beta | 0.256 |
| Beta Downside | 0.109 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.39% |
| CAGR/Max DD | -0.03 |
Description: TAP Molson Coors Brewing January 04, 2026
Molson Coors Beverage Company (NYSE:TAP) manufactures, markets and distributes a broad portfolio of beer and malt-based drinks across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Its lineup spans economy brands (e.g., Coors Light, Miller Lite), premium labels (e.g., Blue Moon, Stella Artois) and fast-growing flavored-malt categories such as hard seltzers (Topo Chico, Vizzy) and ready-to-drink cocktails.
In 2023 the company reported net sales of roughly **$5.2 billion**, with comparable volume down about **2 % YoY** but **adjusted EBITDA margin holding at 14 %**, reflecting cost-containment amid higher commodity prices. Hard-seltzer and RTD segments together delivered **~15 % revenue growth**, offsetting modest declines in traditional core beer volumes.
Key economic drivers include discretionary-spending trends, inflation-linked input costs (barley, aluminum) and shifting consumer preferences toward premium and low-calorie alternatives. At the sector level, the U.S. beer market is contracting (~1 % annual decline), prompting consolidation and a strategic pivot to higher-margin premium and flavored-malt offerings.
For a deeper, data-rich look at TAP’s valuation metrics and scenario analysis, you may find ValueRay’s research platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -2.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.46 > 1.0 |
| NWC/Revenue: -18.86% < 20% (prev -0.16%; Δ -18.69% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.74b > Net Income -2.09b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (197.9m) vs 12m ago -4.86% < -2% |
| Gross Margin: 38.74% > 18% (prev 0.39%; Δ 3835 % > 0.5%) |
| Asset Turnover: 45.30% > 50% (prev 43.86%; Δ 1.44% > 0%) |
| Interest Coverage Ratio: -10.29 > 6 (EBITDA TTM -1.51b / Interest Expense TTM 223.1m) |
Altman Z'' -0.02
| A: -0.09 (Total Current Assets 3.23b - Total Current Liabilities 5.34b) / Total Assets 22.87b |
| B: 0.24 (Retained Earnings 5.58b / Total Assets 22.87b) |
| C: -0.09 (EBIT TTM -2.30b / Avg Total Assets 24.75b) |
| D: 0.39 (Book Value of Equity 4.80b / Total Liabilities 12.20b) |
| Altman-Z'' Score: -0.02 = B |
Beneish M -3.26
| DSRI: 1.02 (Receivables 993.8m/1.02b, Revenue 11.21b/11.68b) |
| GMI: 1.00 (GM 38.74% / 38.77%) |
| AQI: 0.92 (AQ_t 0.66 / AQ_t-1 0.71) |
| SGI: 0.96 (Revenue 11.21b / 11.68b) |
| TATA: -0.17 (NI -2.09b - CFO 1.74b) / TA 22.87b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of TAP shares?
Over the past week, the price has changed by -4.40%, over one month by +2.06%, over three months by +10.47% and over the past year by -10.21%.
Is TAP a buy, sell or hold?
- StrongBuy: 4
- Buy: 4
- Hold: 14
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the TAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51.1 | 7.4% |
| Analysts Target Price | 51.1 | 7.4% |
| ValueRay Target Price | 49 | 3% |
TAP Fundamental Data Overview January 27, 2026
P/S = 0.8703
P/B = 0.9446
P/EG = 8.6201
Revenue TTM = 11.21b USD
EBIT TTM = -2.30b USD
EBITDA TTM = -1.51b USD
Long Term Debt = 3.88b USD (from longTermDebt, last quarter)
Short Term Debt = 2.41b USD (from shortTermDebt, last quarter)
Debt = 6.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.34b USD (from netDebt column, last quarter)
Enterprise Value = 15.10b USD (9.76b + Debt 6.29b - CCE 950.2m)
Interest Coverage Ratio = -10.29 (Ebit TTM -2.30b / Interest Expense TTM 223.1m)
EV/FCF = 13.81x (Enterprise Value 15.10b / FCF TTM 1.09b)
FCF Yield = 7.24% (FCF TTM 1.09b / Enterprise Value 15.10b)
FCF Margin = 9.75% (FCF TTM 1.09b / Revenue TTM 11.21b)
Net Margin = -18.64% (Net Income TTM -2.09b / Revenue TTM 11.21b)
Gross Margin = 38.74% ((Revenue TTM 11.21b - Cost of Revenue TTM 6.87b) / Revenue TTM)
Gross Margin QoQ = 39.47% (prev 40.05%)
Tobins Q-Ratio = 0.66 (Enterprise Value 15.10b / Total Assets 22.87b)
Interest Expense / Debt = 0.89% (Interest Expense 56.0m / Debt 6.29b)
Taxrate = 22.97% (345.3m / 1.50b)
NOPAT = -1.77b (EBIT -2.30b * (1 - 22.97%)) [loss with tax shield]
Current Ratio = 0.60 (Total Current Assets 3.23b / Total Current Liabilities 5.34b)
Debt / Equity = 0.61 (Debt 6.29b / totalStockholderEquity, last quarter 10.33b)
Debt / EBITDA = -3.54 (negative EBITDA) (Net Debt 5.34b / EBITDA -1.51b)
Debt / FCF = 4.89 (Net Debt 5.34b / FCF TTM 1.09b)
Total Stockholder Equity = 12.49b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.44% (Net Income -2.09b / Total Assets 22.87b)
RoE = -16.74% (Net Income TTM -2.09b / Total Stockholder Equity 12.49b)
RoCE = -14.02% (EBIT -2.30b / Capital Employed (Equity 12.49b + L.T.Debt 3.88b))
RoIC = -9.44% (negative operating profit) (NOPAT -1.77b / Invested Capital 18.74b)
WACC = 4.44% (E(9.76b)/V(16.05b) * Re(6.86%) + D(6.29b)/V(16.05b) * Rd(0.89%) * (1-Tc(0.23)))
Discount Rate = 6.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.41%
[DCF Debug] Terminal Value 86.37% ; FCFF base≈1.12b ; Y1≈1.12b ; Y5≈1.19b
Fair Price DCF = 163.1 (EV 35.57b - Net Debt 5.34b = Equity 30.23b / Shares 185.3m; r=5.90% [WACC]; 5y FCF grow -0.19% → 2.90% )
EPS Correlation: -1.01 | EPS CAGR: -27.44% | SUE: -3.64 | # QB: 0
Revenue Correlation: 28.75 | Revenue CAGR: 3.44% | SUE: -0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=13
EPS next Year (2026-12-31): EPS=5.52 | Chg30d=-0.034 | Revisions Net=-6 | Growth EPS=+2.6% | Growth Revenue=-0.2%